Introduction
Advances in innate immunity have highlighted the concept of danger as a proinflammatory trigger with damage-(DAMPs) and pathogenassociated molecular patterns (PAMPs) linked to activation of inflammasomes. Inflammasomes are high molecular weight, intracellular multiprotein complexes that form a scaffold enabling caspase-mediated processing of the proinflammatory cytokines of the interleukin (IL)-1 family . The specific sequence of protein interactions initiated in assembling the inflammasome follows receipt and decoding of an appropriate trigger conveyed via ligand binding to a target pattern recognition receptor. Inflammasomes typically form from the induced assembly of caspase-1, a NOD-like receptor or NLR (NOD meaning nucleotide-binding oligomerization domain), and an adaptor protein, ASC (apoptosis-associated speck-like protein with CARD domain) Mariathasan et al., 2006) . Inflammasome activation is triggered by a diverse array of microbes, microbial toxins or inappropriate activity of host molecules including glucose (Zhou et al., 2010; Stienstra et al., 2012) , urates (Martinon et al., 2006) , b-amyloid and cholesterol (Duewell et al., 2010; Rajamaki et al., 2010) . Following inflammasome assembly, the resultant oligomeric construction yields a transient platform that enables a sequence of enzymatic reactions exemplified by autocatalysis of the inflammatory caspases (caspase-1) and its proteolysis of proforms of the interleukins IL-1b, IL-18 and IL-33 to generate their respective mature, secretory forms. To date, four main types of inflammasomes have been characterized of which the NLRP3 family is the most studied. A variety of autoinflammatory diseases characterized by periodic fever and exacerbated inflammation have been mapped to mutations in genes encoding proteins comprising the inflammasome (Aganna et al., 2002; GoldbachMansky et al., 2006) .
While the majority of pregnancies end in the timely delivery of a healthy newborn, preterm birth (PTB) remains a leading cause of perinatal morbidity and mortality (Goldenberg et al., 2008; Lawn et al., 2014) . Spontaneous PTB is initiated predominantly by bacterial infection via the female genital tract with latent or subclinical infection also linked to preterm delivery. In addition, in developed countries, the increased incidence of maternal metabolic disorders warns of generational shifts in conditions characterized by low-grade, chronic inflammation, originating in part as a result of the in utero environment. Some of these metabolites are themselves triggers of inflammasome activation. There is little information currently available on the role of inflammasomes and their relevance to pregnancy and pregnancy pathophysiology. A wider dissemination of the workings of the inflammasome with respect to reproduction is timely and may provide new insights into the basis of pregnancy-related disorders.
Methods
For this narrative review, PubMed and Medline searches for the inflammasomes were conducted between January 2002 and May 2014. Our search strategy was designed to capture contemporary information on inflammasome biology using the search terms 'inflammasome', 'NLRP1', 'NLRP3', 'NLRC4', 'AIM2', 'DAMPs', 'PAMPs', 'caspase-1', 'interleukin-1' and combinations of these. For the relevance of the inflammasome to pregnancy, the original search terms were then combined with 'innate immunity', 'pregnancy', 'preterm birth', 'placenta', 'maternal obesity'. Original research articles for IL-1 biology and PTB have been included to provide context-specific information.
Inflammation in pregnancy
The earliest immune challenge in pregnancy occurs at fertilization when the paternal and maternal genomes unite forming the diploid zygote. Various mechanisms exist to prevent rejection and elimination of this foreign, yet part-self embryo. Studies by Sir Peter Medawar first advanced the notion of maternal and placental tolerance (reviewed in Billington (2003) and Trowsdale and Betz (2006) ) allowing growth and maturation of the embryo in a relatively, safe, sterile environment enabling it to develop to its full growth potential. During early pregnancy, the embryo is immunologically naïve as it will not yet have been exposed to sufficient antigens to fully activate innate or adaptive immune mechanisms (Levy, 2005 (Levy, , 2007 . This immune immaturity renders the newborn especially vulnerable to pathogens but is also a critical factor in ontogenic development and priming of adaptive immunity in early life. Thus the newborn is primarily reliant upon suboptimal innate mechanisms for immune protection.
Both implantation and parturition resemble inflammatory processes. Inflammation itself is the host's response to injury, stress and infection in which a sequence of coordinated immunological events serve to restore normal tissue homeostasis and resolve infection. Implantation and invasion of the endometrium and spiral arteries utilize cytokines and chemokines from immune cells (natural killer cells, macrophages, dendritic cells) for tissue remodelling and placentation (Moffett-King, 2002; Sargent et al., 2006; Mor et al., 2011) . Similarly, normal labour as an inflammatory event is predicated on observations that demonstrate an increased leukocytic infiltrate in the uterus (Thomson et al., 1999; Young et al., 2002) , and increased mRNA and protein expression for proinflammatory cytokines in cervix, myometrium and fetal membranes (Osman et al., 2003; Sakamoto et al., 2005) at term parturition. Levels of cytokines that include IL-1b and IL-6 are also elevated with normal labour (Opsjln et al., 1993; Ammala et al., 1997; Keelan et al., 1999) . Inflammatory processes are clearly of benefit to mother and fetus during pregnancy, not least by counteracting infection and limiting tissue injury, however an exacerbated inflammatory response is of course detrimental to many organ systems thereby affecting neonatal and maternal outcomes.
Pregnancy pathophysiology
Inflammation is a major component of some pregnancy disorders. The largest category is that of PTB, a syndrome with a multifactorial aetiology. Defined as delivery before 37 completed weeks of gestation, PTB affects 5-12% pregnancies worldwide (Goldenberg et al., 2008) and 1 million deaths annually (Lawn et al., 2014) . In the UK, PTB is estimated to cost the UK public sector £2.9 billion (Mangham et al., 2009) . Some 75% of all PTBs are spontaneous in onset (sPTB) comprising preterm labour (PTL) and preterm premature rupture of membranes (PPROM), of which nearly half are causally linked to intrauterine bacterial infection (Goldenberg et al., 2008) . Babies are at greatest risk of adverse outcomes the earlier they are born (Goldenberg, 2002; Marlow et al., 2005; Costeloe et al., 2012) but some born at late preterm gestations (34 -36 weeks), are compromised compared with term infants (Petrini et al., 2009 ) with negative outcomes that extend beyond childhood (Saigal and Doyle, 2008) . In low to middle income countries, malaria and syphilis are significant causes of PTB (Simmons et al., 2010) .
Microbial invasion of the amniotic cavity is a key factor in sPTB and is present in approximately one-fifth of women with intact membranes (Romero et al., 2006 (Romero et al., , 2007 . In women with PPROM, histological evidence of infection is much greater with approximately one-third of women testing positive at admission, rising to 75% with labour (Romero et al., 2007) and 50-60% delivering within a week of membrane rupture (Mercer, 2003) indicative of the loss of barrier function provided by the fetal membranes.
The main route of infection of the uterine cavity and amniotic fluid is ascent of microbes from the genital tract via the cervix and vagina, by iatrogenic means, retrograde transmission through the Fallopian tubes or by haematogenous spread (a route for systemic infection) (Goldenberg et al., 2000; Romero et al., 2007) . Having traversed the cervix, bacteria then infect the decidua, fetal membranes and lastly the amniotic fluid and fetus. The cervix offers protection from ascending microbial infection as a physical barrier but also due to its abundance of antimicrobial peptides (Hein et al., 2002) . Histological changes in the placenta and the microbes that accompany cervical insufficiency reflect those seen in PTL and PPROM (McElrath et al., 2008) . In a recent study using whole-genome shotgun metagenomics, a unique placental microbiome niche was described that bears greatest similarity to the human oral microbiome over vaginal, gut, skin and airway habitats. This finding provides a basis for the documented links between periodontal disease and PTB (Aagaard et al., 2014) . Both gram-positive and gram-negative, commensals and pathogens have been implicated in triggering PTL with the most common isolated from amniotic fluid belonging to Mycoplasma species, including Ureaplasma urealyticum and Mycoplasma hominis (see Table I for a list of some micro-organisms). This is further supported by the presence of gram-positive and gram-negative microbes detected at the maternofetal interface (Aagaard et al., 2014) . A fetal inflammatory response is observed in pregnancies complicated by PTL with affected infants at increased risk of severe neonatal morbidities including sepsis, periventricular malacia and respiratory distress . One of the main mechanisms connecting infection with PTL is the up-regulation of the cyclooxygenase enzymes by IL-1b which promotes prostaglandin (PG)E 2 and PGF 2 a production with consequent activation of myometrial contractility (Romero et al., 1989 (Romero et al., , 2006 ; however this is a complex area with very few definitive signalling pathways identified.
Inflammation is also a factor in pre-eclampsia (Redman et al., 1999; Redman and Sargent, 2003; Luppi et al., 2006) which presents with de novo hypertension and proteinuria (Brown et al., 2001) . Pre-eclampsia affects 2 -7% of pregnancies (Roberts and Cooper, 2001; Duley, 2009 ) and accounts for a significant proportion of the 30% of iatrogenic preterm deliveries (Goldenberg and Culhane, 2003) . While the origins of pre-eclampsia resulting from impaired trophoblast invasion and spiral artery transformation in early pregnancy (Khong et al., 1986) are widely accepted, numerous hypotheses have been proposed to explain the aetiology and progression of this disease. Currently favoured are maternal endothelial dysfunction, inflammation and oxidative stress Chaiworapongsa et al., 2014) . Preeclampsia exhibits many of the classical features of inflammation and these are exaggerated in late pregnancy (Redman et al., 1999; Redman and Sargent, 2003 Other current foci of pregnancy research are conditions of a metabolic nature with maternal obesity (Ramsay et al., 2002) and gestation diabetes mellitus (GDM) (Wolf et al., 2004; Winzer et al., 2004) displaying evidence of subclinical inflammation. This reflects findings in nonpregnant individuals that both obesity and diabetes are associated with a chronic inflammatory response characterized by abnormal cytokine production, increased acute-phase reactants, and activation of inflammatory signalling pathways (Hotamisligil, 2003) . The prevalence of obesity in pregnancy in the UK has risen from 9-10% in the early 1990s to 16-19% in the 2000s (Heslehurst et al., 2007) . In addition, maternal obesity is associated with negative outcomes for the mother and fetus including increased risk for GDM, pre-eclampsia, stillbirth and miscarriage (Sebire et al., 2001; O'Brien et al., 2003; Bodnar et al., 2005; Catalano and Ehrenberg, 2006) . Moreover adult offspring of obese mothers are also at increased risk of premature death (Reynolds et al., 2013) . Since inflammation may be triggered by microbial and non-microbial causes of fetal and/or maternal derivation, an understanding of inflammatory mechanisms and metabolic disorders of pregnancy may inform new directions in managing the spectra of these diseases.
Elaboration of inflammatory cascades is mediated by structures termed 'inflammasomes' . Originally discovered in 2002, inflammasomes are transient ( 700 kDa) multiprotein cytosolic complexes that act as conduits through which multiple signals are efficiently construed. Resembling the apoptosome, that deciphers death signals by procaspase-9, with apoptosis as the end-point (Riedl and Salvesen, 2007) , inflammasomes facilitate a series of catalytic reactions involving procaspase-1 and terminating with the maturation and release of key cytokines of the IL-1 family . Inflammasomes have been most extensively studied in cells of the myeloid lineage, typically macrophages and monocytes. Their relevance to pregnancy is discussed after detailing the biology of these remarkable structures.
Clear and present danger
Pattern and danger-associated molecular patterns (PAMPs) Traditionally, the main challenge to host defences is from microorganisms that express unique motifs, absent in eukaryotes, termed pathogen-associated molecular patterns (PAMPs) (Medzhitov and Janeway, 2000; Takeda and Akira, 2005) . Combatting such threats from a continual, ever-changing assault from hostile microbes is achieved through an elaborate array of pattern recognition receptors (PRRs) or pattern recognition molecules that recognize PAMPs and are expressed on cells, in intracellular compartments or secreted (Janeway and Medzhitov, 2002) . Of these, the human Toll-like receptor (TLR) family (TLR1-10) has evolved to recognize a panoply of molecules including bacterial flagellin (Hayashi et al., 2001) , lipopolysaccharide (Medzhitov et al., 1997) , peptidoglycan, lipoteichoic acid (Schwandner et al., 1999) and bacterial unmethylated CpG (Hemmi et al., 2000) , amongst others. Having breached the barrier afforded by the plasma membrane, microbes are confronted with a second line of defence in the form of NOD-like receptors (NLRs) (Martinon and Tschopp, 2005; Franchi et al., 2006b) . For the purpose of this review, we will focus on the NLRs.
The family of NLRs encode cytosolic proteins for which 22 human NLR genes have been identified (Ting et al., 2008) . Structurally, each NLR is a trio of core components: a central NOD-like nucleotide-binding domain also called NACHT (for domain found in NAIP, CIITA, HET-E and TP-1), with a region of leucine-rich repeats (LRR) at the C-terminus and an N-terminal effector domain that mediates interactions with other protein partners (Tschopp et al., 2003) . In 2008, the nomenclature pertaining to NLRs was revised and simplified based on the moiety of the N-terminus effector (Ting et al., 2008) . Thus NLRA denotes an acidic activation domain; NLRB has a baculovirus inhibitor of apoptosis domain; NLRC contains a caspase activation and recruitment domain (CARD) while NLRP hosts a pyrin (PYD) domain (Ting et al., 2008) . Both CARD and PYD are members of the death-fold superfamily which enables homotypic interactions between members of the same family (Martinon et al., 2001) . The NACHT domain is essential for receptor activation via ATP-dependent dimerization and oligomerization mediated by an AAA+ cassette (Neuwald et al., 1999) . Detection and ligandbinding, in common with TLRs, is a function fulfilled by the LRR domain. Activation of NLRs is suppressed in resting conditions by interactions between the carboxy terminus of LRRs and the AAA+ cassette, preventing oligomerization . As seen later, PAMP detection sets into play inflammatory signalling cascades organized through intracellular platforms termed 'inflammasomes' . Of those characterized to date, three of the four main inflammasome types contain an NLR; however not all NLR proteins form inflammasomes.
Danger (Damage)-associated molecular patterns (DAMPs)
In 1994, a cogent argument on an alternative to the long-held view of the immune system as the sine qua non for discriminating self from non-self was propounded; the concept of 'danger' as a signal driving adaptive immunity (Matzinger, 1994) . Although controversial, experimental evidence since accrued supports the phenomenon that host-derived molecules are also potent initiators of innate immune defences and inflammation (Gallucci and Matzinger, 2001 ). Referred to as damage-associated molecular patterns (DAMPs or alarmins) (Bianchi, 2007) to distinguish them from PAMPs, these non-microbial 'danger' or 'damage' molecules signify escape from their normal intracellular compartments due to cellular stress or injury (Gallucci and Matzinger, 2001; Bianchi, 2007; Kono and Rock, 2008) and cause sterile inflammation by deploying inflammasomes (Chen and Nunez, 2010) . A point worth noting is that the term DAMPs is used interchangeably with the 'D' denoting 'damage' or 'danger' but 'danger' may be deemed too vague a term to convey much information on the nature of the trigger (Pradeu and Cooper, 2012) . The earliest described DAMPs cross a spectrum of biochemical and physicochemical complexity and include extracellular ATP (Bours et al., 2006) , high mobility group box-1 (HMGB1) nuclear protein (Lotze and Tracey, 2005) and crystalline matter, for example, monosodium urate (Shi et al., 2003) ; further examples of DAMPs and PAMPs are provided in Table I . Inflammatory cascades initiated by DAMPs and PAMPs lead to the release of proinflammatory mediators by deploying inflammasomes. As IL-1 processing by caspase-1 is a core function of inflammasomes, key aspects of these two pivotal proteins are summarized below.
Interleukin-1 cytokines
Belonging to the IL-1 family of cytokines, three members, IL-1, IL-18 and IL-33, are synthesized as precursors lacking a signal peptide sequence that prevents their extrusion from the cell via classical exocytosis (Rubartelli et al., 1990; Arend et al., 2008) . IL-1 exists as either IL-1a or IL-1b and biological actions follow its binding to the IL-1 receptor (IL-1R) with signalling via the intracytoplasmic Toll/IL-1 receptor (TIR) domain (Martin and Wesche, 2002) . This results in translocation to the nucleus of the transcription factor nuclear factor kappaB with subsequent binding to promoter regions on target genes triggering downstream inflammatory pathways. The IL-1 family also includes the IL-1 receptor antagonist (IL-1RA) that can influence IL-1 function by binding to the IL-1R but blocks downstream responses (Dinarello, 2011b) .
Synthesized as pro IL-1b, a 33 kDa precursor which is enzymatically cleaved to generate a functional, processed 17 kDa product, IL-1b is a master cytokine expressed in all immune cells with the capacity to induce its own synthesis (Hiscott et al., 1993) and that of others. It has numerous functions: as the archetypal endogenous pyrogen, an initiator of acute-phase proteins as an effector of T-helper cells, and many more (Arend et al., 2008; Dinarello 2011a, b) . Given its pleiotropy of proinflammatory capacity, IL-1b transcription and release is carefully regulated and proceeds via a double hit mechanism. The first hit emanating from a PAMP or DAMP induces transcription of mRNA for IL-1b which is then translated on free ribosomes, primed for release (Auron et al., 1987) . Critically, unless a second signal is received, pro-IL-1b will not be processed. When the second hit is provided, cleavage and secretion follow in quick succession (Andrei et al., 1999) . This second hit for processing of IL-1b is dependent on potassium (K + ) efflux (Perregaux and Gabel, 1994; Griffiths et al., 1995) , triggered by ATP binding to a purinergic receptor, P2X 7 (Falzoni et al., 1995; Ferrari et al., 1997) and now known to involve inflammasomes. Differences are apparent in the processing of IL-1b, with neutrophils (Mankan et al., 2012; Bakele et al., 2014) and macrophages (Netea et al., 2009; Ward et al., 2010) exclusively requiring a 'double hit' while monocytes are able to release IL-1b following a single stimulus (Netea et al., 2009; Ward et al., 2010) . This differential mechanism is context-specific with macrophages existing in environs teeming with microbes and requiring restraint to circumvent unwarranted inflammation while monocytes need to mount rapid responses on detecting pathogens in the normally sterile bloodstream (Netea et al., 2009) . Unlike IL-1b expression, IL-18 is constitutively expressed and its primary role is in the induction of interferon-g (Arend et al., 2008) . Much less is known about IL-18 (and IL-33) in connection with inflammasome function; hence the emphasis in this review rests on IL-1b.
Caspase-1
Caspases are cysteinyl aspartate proteases that are classed as initiator, effector or inflammatory subtypes based on their physiological roles (Fuentes-Prior and Salvesen, 2004) . Their main function is to cleave proteins at sites at aspartic acid residues . Human inflammatory caspases include caspase-1, -4 and -5 and -12. Caspase-1 is synthesized as a 45 kDa zymogen (Thornberry et al., 1992) possessing a CARD at the N-terminus . Functional proteolytic activity is conferred by monomers of procaspase-1 undergoing homodimerization and autocatalysis generating two active subunits of 10 kDa (p10) and 20 kDa (p20) (Thornberry et al., 1992) that then assemble as a heterodimer (p10/p20). In a similar manner, IL-18 in its proform is also a substrate for caspase-1 (Gu et al., 1997) unlike IL-33 (Fuentes-Prior and Salvesen, 2004) which is not (Luthi et al., 2009) and is, paradoxically, inactivated by caspase-1 (Cayrol and Girard, 2009 ). While IL-1 and IL-18 as substrates for caspase-1 have been intensely studied, another eighty possible candidates are suggested based on a proteomic and bioinformatics evaluation (Agard et al., 2010) but their physiological relevance remains to be clarified. Interestingly, caspase-1 elicits a specific form of cell death termed pyroptosis (Swanson and Molofsky, 2005; Fink et al., 2008) . Originally reported for Salmonella and Shigella and distinct from apoptosis and necrosis, this inflammatory form of cell death results in osmotic lysis, DNA fragmentation and proinflammatory cytokine release (Fink and Cookson, 2005) . Pyroptosis occurs on pyroptosomes, a supramolecular complex assembled following ASC oligomerization (Fernandes-Alnemri et al., 2007) and provides a novel angle on host-pathogen interactions and implications for infection.
Inflammasomes
All known inflammasomes share the same elementary structural template which consists of an integral PRR (typically an NLR), procaspase-1 and the apoptosis-associated speck-like protein containing a CARD (ASC; also known as PYCARD) which harbours an N-terminal pyrin (PYD) domain and a CARD at the C-terminus (Srinivasula et al., 2002) . This configuration of ASC facilitates homotypic associations with other PYD-and CARD containing proteins required for inflammasome assembly by linking the NLR with procaspase-1 (Srinivasula et al., 2002) . The structure of the four known inflammasomes and key proteins is illustrated in Fig. 1 .
Inflammasome subtypes and organization
The NLRP1 (NALP1) inflammasome is the original oligomeric complex discovered consisting of caspase-1, caspase-5, NLRP1 and ASC . It is presently the only known inflammasome containing a FIIND (function to find) domain which undergoes autocleavage to confer functionality (Finger et al., 2012) . Both anthrax lethal factor from Bacillus anthracis (Boyden and Dietrich, 2006) and muramyl dipeptide (Faustin et al., 2007) initiate its activation.
The NLRC4 (IPAF) inflammasome is characterized by the presence of an intrinsic CARD domain that interacts directly with procaspase-1 (Mariathasan et al., 2004) . The main triggers for this inflammasome are bacterial flagellins of gram-negative bacteria with type III or IV secretion systems exemplified by Salmonella typhimurium and Shigella flexneri (Mariathasan et al., 2004; Amer et al., 2006; Miao et al., 2006; Franchi et al., 2006a) . Activation has also been shown to be flagellin-independent (Suzuki et al., 2007) indicating that other, as yet unknown, bacterial ligands are also sensed by NLRC4.
The NLRP3 (CIAS, NALP3, cryopyrin) inflammasome is unique amongst inflammasomes in being responsive not only to microbial cues but also a plethora of chemically diverse non-microbial signals arising from, for example, monosodium urate (Martinon et al., 2006) , glucose (Zhou et al., 2010) extracellular ATP (Mariathasan et al., 2006) as well as PAMPs (Mariathasan et al., 2006; Craven et al., 2009) . The NLRP3 couples directly to the PYD of ASC via its PYD domain to execute function.
The non-NLR AIM2 (absent in melanoma 2 (AIM2)) inflammasome belongs to the HIN200 (haematopoetic expression, IFN-inducible, nuclear localization and length of 200 aminoacid domain) family (Burckstummer et al., 2009; Fernandes-Alnemri et al., 2009) . It is distinct from the NLR inflammasomes in having a HIN group containing a PYD domain that associates with the PYD of ASC to effect function. AIM2 detects double-stranded DNA within the cytosol Rathinam et al., 2010) for which direct binding has been demonstrated (Hornung et al., 2009) .
Inflammasome assembly
The formative steps in assembly of all inflammasomes occur on receipt of an appropriate trigger which induces a conformational change that signals ATP-dependent self-oligomerization . Once activated, the PYD domains of NLRP1, NLRP3 and AIM-2 (all lacking CARD) associate with ASC and recruit procaspase-1 monomers by clustering (Schroder and Tschopp, 2010) . Through this induced proximity, CARD-CARD associations ensue resulting in autoproteolysis of procaspase-1 into its active subunits thus catalysing the processing of proIL-1b into active IL-1b Schroder and Tschopp, 2010) . Recently, a common mechanism of assembly involving nucleation of PYD domains of ASC, CARD and caspase-1 has been proposed for the NLRP3 and AIM2 inflammasomes (Lu et al., 2014) . Near atomic resolution imaging depicts the PYD-containing inflammasomes as filamentous (Lu et al., 2014) .
Mechanisms of inflammasome activation
Once assembled, the actual signal(s) whereby the inflammasome is activated has engendered much curiosity; specifically the 'switch' that turns on the inflammasome. Quite how such structurally and chemically diverse molecules activate the NLRP3 inflammasome remains perplexing but is not thought to require direct contact between the PAMP/ DAMP and sensing domains of the inflammasome. Research on this aspect has emerged mostly from in vitro studies of the NLRP3 inflammasome and three main mechanisms have been postulated. Figure 2 depicts the intracellular machinery that comprises the inflammasome and its linkage to the three main activation pathways that include the P2X 7 receptor, reactive oxygen species (ROS) and lysosomal destabilization. and IL-18 into their corresponding processed entities (Perregaux and Gabel, 1994) through the purinergic P2X 7 receptor (Falzoni et al., 1995; Ferrari et al., 1997) . Abundant in haematopoietic cells (Collo et al., 1997; Ferrari et al., 2006) , the P2X 7 receptor is an ion channel gated by extracellular ATP which generates an initial cation current on binding of the nucleotide (Surprenant et al., 1996) and has since been shown to link with the NLRP3 inflammasome (Mariathasan et al., 2004; Duncan et al., 2007) . Low cytosolic K + concentrations also initiate activation of NLRP1 , NLRC4 (Arlehamn et al., 2010) and AIM2 Fink et al., 2008; Muruve et al., 2008) . Intriguingly, activation of caspase-1 by intracellular bacteria does not require ATP or intracellular K + depletion . A distinct second phase of the P2X 7 ion current, indicative of large pore formation, is also observed in the presence of ATP Falzoni et al., 1995; Surprenant et al., 1996) and in macrophages this pore activity has since been attributed to the pannexin-1 hemichannel associating with P2X 7 (Pelegrin and Surprenant, 2006) ; the pannexin pore is the gateway exploited by microbes for the intracellular delivery of toxins and consequent inflammasome activation .
ROS pathway
Molecules involved in sterile inflammation are associated with transient ROS generation (Fubini and Hubbard, 2003) . It is not clear how ROS trigger such activation but one proposed mechanism suggests that dissociation of constitutively-expressed thioredoxin-interacting protein from thioredoxin allows the former to bind to the LRR domain of the inflammasome (Zhou et al., 2010) . Another route of inflammasome activation by ROS is postulated as being due to NADPH oxidase (Nox) activity (Dostert et al., 2008) . However, contradictory effects were reported in patients with chronic granulomatous disease who carry a mutation in the p22phox gene and in whom IL-1b secretion as a measure of inflammasome activity was Nox-independent (van Bruggen et al., 2010) . A role for ROS signals emanating from damaged mitochondria has also been cited as a source of NLRP3 activation (Zhou et al., 2011) as well as NLRP3 oligomerization induced by the mitochondrial antiviral signalling protein, MAVS (Park et al., 2013) and deubiquitination of the inflammasome (Juliana et al., 2012) .
Lysosomal rupture pathway
Sterile inflammation may also evoke inflammasome activation following damage by crystalline or particulate matter. Such compounds including alum, silica, asbestos, adjuvants and cholesterol (Duewell et al., 2010; Rajamaki et al., 2010) cause lysosomal disruption following their phagocytosis by macrophages. Consequently, lysosomal proteases such as cathepsin D are released into the cytosol and are then sensed by as yet unknown substrates triggering NLRP3 activation Hornung et al., 2008) . Use of a cathepsin B inhibitor partially impaired inflammasome activation providing some support for the mechanism ; however, the possibility of off-target effects of these small molecules cannot be excluded. None of the three mechanisms highlighted above serve as the sole trigger for inflammasome activation nor do they fully explain activation of the NLRP3 inflammasome or indeed the three others. It is probable that NLRP1, NLRC4 and AIM2 will be triggered by alternative stimuli; hence new pathways and molecules will certainly emerge as we discover more about the control of these unique scaffolds.
Inhibition and termination of inflammasome activity
With the formidable potential of the inflammasome to cause damage by aggravated inflammatory responses, normal cellular processes must exist to regulate and terminate inflammasome activity. Crucially, the multimeric nature of the inflammasome and the sequential processing of both caspases and proinflammatory cytokines introduces a series of checkpoints that prevent inappropriate inflammation or cell death by regulating expression and activity of constituent proteins. Thus procaspase-1 (Thornberry et al., 1992) and ASC are expressed at rest but are inactive (Bryan et al., 2009) . While procaspase-1 levels are similar to those for other caspases studied, the activity of the mature form, caspase-1, is restricted by its lability and substantially shorter halflife (Walsh et al., 2011) mediated by autoproteolysis or dissociation into catalytically inactive p20 and p10 subunits (Talanian et al., 1996) . In the case of ASC, the protein resides within nuclei of resting macrophages and monocytes but is rapidly mobilized to the cytosol following stimulation (Bryan et al., 2009) . ASC then forms 4-6 mm aggregates in the cytosol and colocalises with NLRP3 in intracellular vesicles (Mariathasan et al., 2004; Bryan et al., 2009) . Interestingly, NLRP3 expression is either induced following a priming signal by cytokines or PRR ligands (O'Connor et al., 2003; Bauernfeind et al., 2009; Franchi et al., 2009) , is suppressed by chaperone proteins (Poyet et al., 2001; Mayor et al., 2007) or relocates to the perinuclear space on stimulation with DAMPs (Zhou et al., 2011) .
In terminating inflammasome activity, autophagy as the cell's intrinsic mechanism for removing damaged proteins and organelles has been suggested (Shi et al., 2012) . Alternative mechanisms include inactivation of caspase-1 (Druilhe et al., 2001) or proteins that interfere with caspase-1 oligomerization such as the CARD-only proteins (Kersse et al., 2007) and ICEBERG (Humke et al., 2000) . The effector protein ASC may also be blocked by the decoy ASC pyrin-only protein (POP2), competing with it to inhibit inflammasome formation (Bedoya et al., 2007; Atianand and Harton, 2011) . Nitric oxide has been shown to inhibit the NLRP3 inflammasome likely by S-nitrosylation (HernandezCuellar et al., 2012). Endogenous inhibitors also include antiapoptotic Bcl-2 and Bcl-x proteins that prevent NLRP1 activation by interfering with ATP binding to the NACHT domain . Recently, CRID3, a synthetic cytokine release inhibitory drug, inhibited ASC oligomerization in NLRP3 and AIM2 but not NLRC4 inflammasomes (Coll and O'Neill, 2011) . The sulphonylurea glibenclamide has also been shown to inhibit the NLRP3 inflammasome downstream of the P2X 7 receptor (Lamkanfi et al., 2009) . function of the inflammasome is to enable the cleavage of precursor forms of IL-1b and IL-18 to generate the processed bioactive cytokine that is then released to the extracellular space. Prior to translation and processing, IL-1b must first be synthesized in response to a trigger from e.g. pattern-associated molecular patterns (PAMPs) via tolllike receptors (TLRs) and the transcription factor nuclear factor kappa B (NFkB (HIT 1). Autoproteolysis of procaspase-1 to caspase-1 then cleaves the proform into IL-1b on inflammasomes (HIT 2). Inflammasomes are activated by PAMPs (from e.g. Salmonella, Shigella, Legionella or flagellins, muramyl dipeptide) or by sterile inflammation by DAMPs (glucose, cholesterol crystals, monosodium urate, haemozoin). Inflammasome assembly is triggered by K + efflux following activation of a membrane-bound purinergic receptor, P2X 7 by ATP binding to its extracellular mouth. This appears to be a universal mechanisms for inflammasome activation (red arrows) but not necessary for activation by intracellular pathogens that can use pannexin. Crystals phagocytosed by the cell enter lysosomes (lyso) and activate the inflammasome by destabilization that causes leakage of proteases into the cytosol (pathway 1) and are detected by the inflammasome followed by activation in response to K + leaving the cell (pathway 2). Production of reactive oxygen species (ROS) by mitochondria can also activate inflammasomes (pathway 3). In the mature form, IL-1b and IL-18 are then able to exit the cell, not by exocytosis as these cytokines lack a signal sequence, but by plasma membrane blebbing and vesicle shedding, by specialized secretory lysosomes or direct release via transporters.
Inflammasomes: insights from disease
The genetic basis for certain debilitating autoinflammatory syndromes emerged from the discovery of the gene named CIAS1 (cold-induced autoinflammatory syndrome-1 encoding the cryopyrin protein) present in cryopyrin-associated periodic syndromes (CAPS) (Hoffman et al., 2001a) . Characterized by dominant, heterozygous, gain-of-function mutations in the CIAS (NLRP3) gene, these inherited disorders include Muckle-Wells syndrome (MSW), familial cold autoinflammatory syndrome (FCAS) and neonatal-onset multisystem inflammatory disease (Hoffman et al., 2001a, b) . Phenotypically, they manifest with symptoms of relapsing fever, an urticaria-like rash and joint problems (Hoffman et al., 2001b) as a result of enhanced IL-1b activity in macrophages (Agostini et al., 2004; Ryan and Goldbach-Mansky, 2008) . Resolution of symptoms in CAPS is achieved using a recombinant form of the lL-1R antagonist anakinra (Goldbach-Mansky et al., 2006) and more recently canakinumatakinun (a neutralizing IL-1 monoclonal antibody) or rilonacept, a synthetic long-acting IL-1 inhibitor (GoldbachMansky et al., 2008; Hoffman, 2009 ). More recently, a CIAS1 polymorphism has been linked to mycoplasma infection in women with infertility with the authors proposing that the decreased expression of NLRP3 leads to reduced active IL-1b hence the preponderance of mycoplasma (Witkin et al., 2010) . Mutations in the PYRIN domain also give rise to other rare forms of autoinflammatory syndromes such as Familial Mediterranean Fever (Chae et al., 2006) .
Mutations in the NLRP1 gene have been identified in generalized vitiligo (Jin et al., 2007a, b) and suggested in Crohn's disease (Cummings et al., 2010) with the adverse effects of autoinflammation probably due to the direct association between the CARD of NLRP1 and procaspase-1. Recent studies suggest that defective NLRP3 signalling in the gut contributes to inflammatory bowel disease through increased permeability across the epithelial barrier and the induction of an impaired immune response against invading commensals (Zaki et al., 2011) . Hyperactivity of inflammasomes is also linked to gout (Martinon et al., 2006) , pseudogout (Martinon et al., 2006) and type II diabetes (Larsen et al., 2007; Grant and Dixit, 2013) . Glucotoxicity in pancreatic b-cells is induced by IL-1b in response to high glucose (Maedler et al., 2002) and mice with a gene knockout for NLRP3 and ASC exhibited improved insulin signalling in adipose and other insulin-sensitive tissues (Vandanmagsar et al., 2011) . Interestingly, type II diabetic patients demonstrated improved glycaemic control on treatment with anakinra (Larsen et al., 2007) supporting diabetes as an autoinflammatory disease (McGonagle and McDermott, 2006) .
Inflammasomes in pregnancy
Many facets of potential inflammasome involvement are reflected in normal pregnancy and pregnancy-specific disorders. Here we explore the evidence for, and implications that arise via, aggravated or inappropriate inflammatory responses in gestation.
Early pregnancy
The role of the inflammasome in early pregnancy and associated complications has received scant attention to date. Establishing a pregnancy requires several hurdles to be circumvented beginning with fertilization.
In this context, evidence for an association between MWS and male subfertility has been reported (Tran et al., 2012) . In addition, semen of men with spinal cord injury, characterized by a normal sperm count but reduced sperm motility and viability, has been shown to be high in IL-1b, IL-18, caspase-1 and ASC compared with control subjects (Zhang et al., 2013) . Further analysis identified localization of ASC protein to sperm midpiece in contrast to its absence in males without spinal cord injury, leading to the conclusion that abnormal semen quality is connected to activation of innate immunity (Zhang et al., 2013) . Neutralizing ASC activity using an anti-ASC polyclonal antibody improved motility providing a promising approach to improving male fertility in this patient group (Ibrahim et al., 2014) . Intriguingly, familial or recurrent hydatidiform mole (HM), a form of gestational trophoblastic disease characterized by a lack of embryonic growth, has been linked with at least 5-13 mutations of the NLRP7 (NALP7) gene located on chromosome 19q13.42 (Murdoch et al., 2006; Wang et al., 2009) . Expressed NLRP7 generally inhibits transcription of pro-IL-1b and its processing to the mature form, with NLRP7 mutations of HM preventing these effects (Radian et al., 2013) . Since familial HM comprises only a minority of this multifactorial condition, more investigations into the mechanisms whereby NLRP7 causes HM are needed.
Evidence for inflammasomes in early pregnancy has been shown by transcription of NLRP1, NLRP3, NLRC4, PYCARD, caspase-1 and IL-1b genes in human first trimester cytotrophoblasts, decidual stromal cells and decidual endothelial cells stimulated with lipopolysacharride (LPS) (Pontillo et al., 2013) . In cytotrophoblasts and decidual stromal cells, LPS augmented mRNA expression of caspase-1 and IL-1b and the specific up-regulation of NLRP3 of the three NLRs tested (Pontillo et al., 2013) . Moreover, indicative of functional activity, LPS enhanced secretion of IL-1b from first trimester cytotrophoblasts and decidual stromal but not endothelial cells (Pontillo et al., 2013) . These results support a role for decidual stromal cells in immune defence and cytokine production. Release of IL-1b from cytotrophoblast cells implies that even in early pregnancy, the placenta plays a role in host defence. Inflammasomes appear to be involved at several levels in early pregnancy including germ-line disorders and infections linked to spontaneous abortion, miscarriage (see below for antiphospholipid syndrome) and male/female infertility. Further investigations are needed to elucidate the mechanisms that result in dysfunction of inflammasomes in early pregnancy.
Term pregnancy and parturition
As stated earlier, proinflammatory cytokines are spatially and temporally expressed in fetoplacental compartments with impending labour (Thomson et al., 1999; Young et al., 2002) . Cytokines are not thought to cross the placenta (Aaltonen et al., 2005) thus their detection in amniotic fluid points to local fetoplacental production and in the case of IL-1b and IL-18, the cellular machinery to generate bioactive product.
In studies conducted using fetal membranes obtained prior to and after the spontaneous onset of labour, a potential role for the inflammasome was inferred from increased gene transcription of caspase-1 (Lappas, 2014b) . This observation was also mirrored in myometrium (Lappas, 2014b) . Moreover, in explant models of fetal membranes and myometrium, LPS-stimulated bioactive IL-1b was detectable in culture supernatant with release potentiated by ATP and nigericin and sensitive to pharmacological blockade using a P2X 7 inhibitor and the pannexin-1 blocker carbenoxolone (Lappas, 2014b) . Our own data from human cord blood leukocytes demonstrate that extracellular ATP promotes secretion of IL-1b from labouring and non-labouring women in line with activation of the P2X 7 receptor (Warren et al., 2008) . Levels of the natural ligand, ATP, for the P2X 7 receptor, are tightly regulated in vivo yet in accordance with its role as a 'danger' signal, high (mM concentration) extracellular ATP levels are required to activate the P2X 7 receptor. In the pregnant human uterus, elevated ATP levels could result from (i) its release from endothelial cells in cord blood vessels (Yegutkin et al., 2000) and (ii) mechanical trauma (Pedersen et al., 1999) possibly from uterine stretch or contractions. Expression of the rat myometrial P2X 7 receptor increases prior to labour and in an animal model of PTB, P2X 7 mRNA and protein increased a further 18-to 22-fold at Day 19 of gestation indicating a distinct activation of inflammatory pathways in PTB (Urabe et al., 2009 ). This group also reported an ATP-activated conductance in rat myometrium with a pharmacological profile consistent with P2X 7 stimulation (Miyoshi et al., 2010) .
Unstimulated fetal membranes with intact chorion and amnion, expressed mRNA for all ten human TLRs, NLRP1, NLP3, ASC and caspase-1 . In this study, it was also shown that active IL-1b levels were higher in fetal membranes after stimulation with PAMPs typified by LPS, peptidoglycan and flagellin; caspase-1 dependent secretion of IL-1b was only observed in response to TLR-2, -4 and -5, in contrast to NOD1 and NOD2 ligands where IL-1b release was caspase-1 independent . While the NLRs NOD1 and NOD2 are not known to form inflammasomes, both of these NLRs can interact indirectly to influence inflammasome activation (Hsu et al., 2008) . Moreover, following infection with Chlamydia trachomatis, IL-1b release from trophoblasts was shown to be ASC-independent, mediated instead by NOD1 . Nevertheless, from this limited data, evidently gestational tissues express components of inflammasomes as well as the upstream signalling pathways and the corresponding effector cascades leading to IL-1b release. The ontogeny of inflammasome expression in the various cells and tissues of the materno/fetal/placental axis may be an important factor in combatting infection.
Preterm labour
The placenta is an imperfect barrier and susceptible to bacterial infection once its integrity is breached as evident in chorioamnionitis. Thus, investigating whether pathogens engage inflammasomes as part of their weaponry in initiating PTL and PPROM represents a vital area of future pregnancy research. In the absence of overt clinical evidence, the role of infection in the onset of PTL is a conundrum given the fact that 16S rRNA as a proxy for bacterial presence is detectable in fetal membranes after preterm delivery and also in membranes collected at term from labouring and non-labouring women (Steel et al., 2005; DiGiulio et al., 2008) . Currently, there is little direct evidence available for exaggerated inflammasome activity as a factor in causing PTB yet several indirect lines of evidence hint at this potential link. Thus, caspase-1 levels measured in amniotic fluid were highest in women with PTL with confirmed intrauterine infection compared with women delivering at term or preterm without infection . Caspase-1 was not detectable in amniotic fluid obtained at midgestation . Levels of the DAMP high mobility group box-1 (HMGB1) were also found to be higher in amniotic fluid of women with preterm premature rupture of membranes than those with PTL with intact membranes . Immunoreactivity for HMGB1 was localized to neutrophils and macrophages of the chorioamniotic layer . These observations, while showing that tissue injury, unsurprisingly, is associated with extrusion of HMGB1, do not provide information on mechanisms. Interestingly, a recent study examining polymorphisms in five genes associated with inflammation in Black, White and Hispanic Americans observed an altered frequency for the genes CIASI (NLRP3) and IL-RN (encodes the IL-1 receptor antagonist) leading the authors to conclude that women with African ancestry may be genetically predisposed to PTB (Jaffe et al., 2013) . In view of the heritable cryopyrin-associated diseases and the fact that the strongest predictor of PTB is maternal or fetal genetic predisposition (Clausson et al., 2000) , further investigation of genetic polymorphisms encoding proteins implicated in inflammasome function are warranted. Further, in view of the sheer diversity of DAMPs, commensal bacteria and pathogens resident in the genital tract, investigating how the inflammasome is enlisted to drive or limit inflammation will help in elucidating mechanisms underlying PTL. Table II records the link between the most common microbes isolated from amniotic fluid and evidence (see references listed in Supplementary Data) for any interactions with inflammasomes.
Pre-eclampsia
A potential involvement of the inflammasome in pre-eclampsia is hypothesized since metabolites such as uric acid and ROS could be considered danger signals driving inflammation. Recently Xie et al. reported raised mRNA levels of TLR2, TLR4 and IL-1b with elevated protein expression for cryopyrin (NLRP3) in neutrophils of women with preeclampsia compared with normal pregnancy (Xie et al., 2010) . The increase in cryoprin was even more striking in the early onset pre-eclamptic group but IL-1b levels were not measured in serum to either confirm or refute an association with the higher levels in pre-eclampsia. In fact, neutrophils have been little-studied with respect to the inflammasome compared with mononuclear cells. However, they secrete significant amounts of IL-1b on stimulation with LPS and nigericin, a K + ionophore (Mankan et al., 2012) . In addition, resting neutrophils purified from whole blood, expressed ASC, caspase-1, NLRP3 and AIM2 with lower expression of NLRC4 and NLRP1b leading the authors to conclude that the NLRP3/ASC/caspase-1 axis in neutrophils is indeed functional (Bakele et al., 2014) . This finding was confirmed for both IL-1b and IL-18 (but not IL-1a and IL-13) in later studies where a highly pure neutrophil preparation was employed (Bakele et al., 2014) . In terms of a direct association between DAMPs and pre-eclampsia, raised plasma levels of uric acid are apparent before clinical signs of the disease (Redman and Bonnar, 1978; Koopmans et al., 2009; Gowri and Al-Zakwani, 2010 ) but controversy exists on their clinical utility. In human first trimester villous trophoblast and two trophoblast cell lines (Sw.71 and HTR-8/SVneo), monosodium urate (MSU) promoted IL-1b secretion via NLRP3-inflammasome activation indicative of its proinflammatory effects (Mulla et al., 2011) . The fact that the Sw.71 trophoblast cell line expresses constitutively high levels of pro-IL-1b removes the need for the first hit in the IL-1b production pathway (Mulla et al., 2011) . A previous study highlighted mRNA expression for NLRP1, NLRP3 and ASC mRNA and translation to protein in human syncytiotrophoblast, cytotrophoblast and the Sw.71 cell line (Abrahams, 2011) but the functional significance of this observation has not been tested further. In a recent study, the NLRP3 inflammasome was also implicated in the effects of antiphospholipid syndrome in recurrent miscarriage, fetal demise (Abrahams, 2011) and placental dysfunction in antiphospholipid syndrome-induced pre-eclampsia ). An intriguing aspect of a potential disease mechanism in pre-eclampsia is the shedding of syncytiotrophoblast microparticles and their export into the maternal circulation which has been linked to a maternal inflammatory response . It is conceivable that these microparticles can act as DAMPs and that the exaggerated inflammatory state in pre-eclampsia originates from hyperactive inflammasome activity.
Metabolic dysfunction
During pregnancy, through the actions of human placental lactogen, maternal insulin resistance develops in order to ensure the ready availability of glucose to the fetus as its main energy substrate (Buchanan and Xiang, 2005) . In cases of GDM, the fetus utilizes copious amounts of glucose underlying the macrosomia associated with this disorder. In insulin resistance, the NLRP3 inflammasome mediates the release of IL-1b release via a caspase-1 dependent mechanism (Vandanmagsar et al., 2011) . IL-1b may itself inhibit both tyrosine phosphorylation and gene expression of insulin receptor substrate, IRS-1 (Jager et al., 2007) . On comparing adipose tissue of women with GDM with a normal glucose tolerant cohort, several lines of evidence emerge in favour of the involvement of the inflammasome (Lappas, 2014a) . Although mRNA levels for IL-1b were unchanged in adipose tissue of the two groups, IL-1b release was greater in the GDM group, as were levels of active caspase-1 (p35 and p10) (Lappas, 2014a) . Furthermore, adipose tissue explants from women with GDM, treated with IL-1b had reduced expression of glut-4 mRNA and protein in addition to reduced glucose uptake (Lappas, 2014a) . Finally ATP pre-incubation stimulated IL-1b production while levels of IL-6 and Il-8 were unaffected (Lappas, 2014a) .
The neonate
The switch to an extrauterine existence necessarily presents immune challenges to the neonate. For the first weeks of life, infants are particularly susceptible to infections even from commensal microbes. They have little memory cell-mediated or antibody-mediated immunity as a consequence of their anatomically-isolated early life (Adkins et al., 2004) . Postnatally, additional adaptations are vital as the neonate's mucosal surfaces are challenged by combining the need to accommodate commensal microbes yet protect itself from pathogens. Using a fetal rat model Kempster et al. showed that mRNA transcripts of the inflammasome components PYCARD, caspase-1 and nlrp6 were higher in intestinal epithelia but not in lung at late gestation (Kempster et al., 2011) demonstrating differential regulation. IL-18 expression while absent in preterm animals was present in both active and inactive forms suggestive of processing in neonates indicating a maturation of the gastrointestinal tract in the perinatal period (Kempster et al., 2011) . Of interest is also the observation that monocyte-derived dendritic cells (MoDCs) of newborns express a functional inflammasome, based on caspase-dependent mediated IL-1b release although levels were significantly lower than adult MoDcs (Philbin et al., 2012) . The authors attributed this to reduced generation of the active 10 kDa caspase subunit (Philbin et al., 2012) . The NLRP3 inflammasome has also been implicated in hypoxic-ischaemic encephalopathy based on the presence of metabolic acidosis, elevated uric acid (Hoffman and Wanderer, 2010) and raised IL-1b levels in cerebrospinal fluid from newborns (Wanderer, 2009 ). Since extremely preterm (,28 weeks) neonates are susceptible to hypoxic brain injury and neonatal sepsis, animal studies using IL-1b targeted therapies (Girard et al., 2008 (Girard et al., , 2010 Leitner et al., 2014) would provide proof of concept in manipulating inflammasome function to limit brain injury. Many of the components involved in the inflammasome are candidates in mediating this form of brain injury. No - 7, 26 No -a Details of references 1 -26 can be found in Supplementary Data.
Mycoplasma hominis Yes
In summary, Fig. 3 depicts the main pregnancy syndromes discussed, the causal factors and associated disease outcomes.
Future perspectives
The unremitting nature of PTB and the escalation of births associated with maternal metabolic disorders that tend to result in post-term pregnancies (Heslehurst et al., 2008; Arrowsmith et al., 2011) necessitate new approaches to the prediction, diagnosis and treatment of these syndromes. Combined, these conditions account for a sizable proportion of feto-maternal morbidity and mortality. If the mechanisms of IL-1b release within the context of pregnancy for eventual screening and therapy are to be realized, then an appreciation of how release of this cytokine is controlled is necessary.
In most cases of PTL, tocolysis provides only limited respite. Few markers of impending PTB are used in the clinic and in predicting PTB in an asymptomatic population, there are few tools at present that are of use. A recent review article suggests that fetal fibronectin (FFN) is most promising with a likelihood ratio of 4 for PTB before 34 weeks (Chan, 2014) . FFN has high specificity but a mixed sensitivity that diminishes with gestational age (Goldenberg et al., 1996) . Another possibility is the transvaginal measurement of cervical length which is reported to be predictive of PTB in all populations studied (GrimesDennis and Berghella, 2007) . Of note, for this article, inflammatory markers including cytokines and C-reactive protein were not useful in this population (Grimes-Dennis and Berghella, 2007) . However, we would argue that recent developments merit a further evaluation of these parameters.
With respect to infection and PTB, many of the pathways utilized by pathogens to evade host defences have not been fully explored. Bacteria have developed ingenious methods for evading host defences and a number of bacterial products including muramyl dipeptide and flagellins activate inflammasomes as does malarial hemozoin (Dostert et al., 2009) . The latter is interesting in light of the burden of PTB attributable to malaria (Simmons et al., 2010) .
In contrast to bacteria, we know very little about the link between viral infections and PTB. Tsekoura et al. reported that adenoviral infection of the placenta was associated with PTB and histological evidence of chorioamnionitis (Tsekoura et al., 2010) . Interestingly, production of IL-1b from fetal membranes stimulated with viral single-stranded RNA was reduced by over half in the presence of a caspase-1 inhibitor (Bakaysa et al., 2014) . In terms of outcomes, women with hepatitis B or hepatitis Ascending bacterial infection is the main cause of spontaneous preterm birth which includes preterm labour and preterm premature rupture of membranes. A model is proposed whereby bacteria and viruses activate the appropriate inflammasome by signalling danger. Release of IL-1b results in premature activation of myometrial contractility which is associated with adverse neonatal outcomes in the form of brain injury, sepsis, respiratory distress. Maternal obesity is a state of chronic inflammation and generation of DAMPs in the form of free fatty acids. It may coexist with gestational diabetes which itself produces the DAMP, glucose. Increased levels of proinflammatory cytokines are hallmarks of metabolic disorders that can affect the future health of the fetus as it is constantly exposed to high levels of glucose and fatty acids in utero. In addition, mothers who are obese are themselves at an increased cardiovascular risk. Pre-eclampsia presents with high blood pressure and proteinuria. It is also associated with dyregulated lipids, endothelial dysfunction, oxidative stress and is a proinflammatory state. Urates as DAMPs and even proteinuria may exacerbate the inflammation observed via the inflammasome. During pregnancy, trophoblast debris is constantly shed and able to enter the maternal circulation. It is then able to activate maternal inflammatory responses as it is foreign DNA to the mother. This may be a trigger for inflammasome activation. Pre-eclampsia is also associated with increased maternal cardiovascular risk in later life.
C were at greater risk of PTB and GDM, respectively (Reddick et al., 2011) . The relationship between viral infection and pregnancy outcomes has been examined using a mouse model where it determined that the presence of the herpes virus sensitized the uterus to bacterial infection . Furthermore, viral infection of the cervix compromised the ability of the uterus to prevent bacterial infection (Racicot et al., 2013) . In light of the synergy between bacterial pathogens and viruses in worsening inflammation in pregnancy, it would be timely to explore whether the inflammasome (possibly AIM2) plays a role in enabling such interactions.
Neither has inflammation in pregnancy been targeted with antiinflammatory agents to manage or treat PTB. Drugs with antiinflammatory actions have been used in women with PTL; high dose dexamethasone by default, as it is principally used to mature the fetal lung but notably is used in association with conventional tocolytics so its effect on labour is hard to assess; it is true to say that at the point of being used, in established PTL, it seems to make little difference. Antibiotic prophylaxis shows no improvement in neonatal outcomes in women with PTL with intact membranes (Flenady et al., 2013) . Antimicrobial peptides are a potential alternative to antibiotics with their potent microbicidal activity. Indeed, the cathelicidin-derived peptide LL37 induces IL-1b processing and also activates the P2X 7 receptor (Elssner et al., 2004) ; hence the actions of defensins and other groups of antimicrobials are worth exploring further. The prospect of a possible intervention to reduce the incidence of PTB is tantalizing and is ultimately the rationale for research into inflammatory processes in pregnancy. The ideal is a situation whereby we can reliably predict, early on, asymptomatic pregnant women who are likely to go into PTL and have a safe intervention to prevent that happening.
The pathogenesis of PE is one of the most studied and scrutinized topics in obstetrics and is largely considered a disease of defective implantation. It is pertinent to consider new factors and review existing targets, such as urates and ROS, in light of their associations with the inflammasome. A potentially exciting area would be the role of microparticles and the possibility that inflammasome (possibly NLRP3) activation exaggerates maternal endothelial dysfunction by adverse endothelialleukocyte interactions. Our presumption is that NLRP3 is the most likely target for shed microparticles transporting fetal DNA given the diversity of molecular signals that activate NLRP3.
The predicted increase in maternal obesity and GDM is likely to constitute an even greater disease burden over the next decade. The source of elevated proinflammatory cytokines typified by IL-1b in any of these pregnancy disorders is either the result of activation of the fetal inflammatory response syndrome or damage to the maternal-placental axis by DAMPs. This raises the unanswered question of whether the apparent inflammation arises from the maternal or fetal compartment. In the case of the maternal circulation, 'damage' may have multiple origins, be it PAMPs or DAMPs. For example, high extracellular glucose, or MSU are DAMPs and may explain the inflammation that accompanies both acute and chronic inflammation by engaging inflammasomes. Importantly, elevated levels of circulating free fatty acids as observed in obesity and diabetes have been proposed as the 'second hit' (instead of ATP) required for IL-1b processing. Via this mechanism, palmitate activated the NLRP3 inflammasome in macrophages via an adenosine monophosphate-activated protein kinase (AMPK) -ROS pathway which led to IL-1b-mediated insulin resistance in target tissues (Wen et al., 2011) . This overnutrition hypothesis could potentially be a mechanism whereby fetal exposure to high glucose or circulating free fatty acid levels in the placenta can reprogramme metabolic pathways that alter risk to adult chronic diseases such as Type II diabetes and cardiovascular disorders. The same is true for maternal obesity and GDM where we now have clues regarding cholesterol interactions with the NLRP3 inflammasomes (Duewell et al., 2010; Rajamaki et al., 2010) that will allow us to probe these interactions further in pregnancy. Indeed, the endocrine nature of pregnancy provides an opportunity to investigate potential hormonal influences on the inflammasome in leukocytes given anti-inflammatory effects of progesterone.
The lack of biomarkers and drugs to treat the syndromes described herein stem from a paucity of knowledge regarding the immunopathology underlying these complex diseases, thus alternative therapeutic approaches should incorporate strategies that target pathways earlier in the inflammatory cascade. The rapidly burgeoning field of inflammasome biology with new molecules and pathways is entering the foray. While IL-1b is considered the end product of inflammasome activation, recent findings indicate that this may not be the case always; inflammasome activation in vivo has been shown to trigger an eicosanoid storm (von Moltke et al., 2012) . Many of the metabolites produced through this 'storm' are eicosanoids including PGE 2 , 12-hydroxyeicosatetraenoic acid (12-HETE) and thromboxanes-all three are demonstrated to have roles in reproduction. Indeed, raised placental 12-HETE levels have been measured in pre-eclamptic placenta (Pearson et al., 2010) . Thus these observations are of direct relevance to pregnancy and justify exploring such phenomena during gestation.
The decade following the discovery of the inflammasome has produced fascinating insight into the intricacies of enzymes and cytokines in the amplification of inflammatory responses. Initially identified as a vehicle for IL-1b release, inflammasomes appear to have the capacity to generate alternative signalling mediators as end-points thus novel pathways may emerge from future studies. One must also caution against attributing all of IL-1b activities and effects to be via the inflammasome (Netea et al., 2010; Kono et al., 2012) . It is also noteworthy that the majority of the findings of inflammasome activity have used in vitro assays and models. It is probable that in vivo mechanisms will differ and as our knowledge of these develops, more inflammasome complexity is likely to be unravelled. Finally, the genetics of autoinflammatory disorders has been instrumental in manipulating the inflammasome for therapeutic benefit and is a probable route whereby the genetics of PTB and may be further explored in order to identify women at risk. Moreover, IL-1 targeted therapies that have been successfully administered to treat hereditary autoinflammatory disorders and also hold promise for type II diabetes, raise the possibility of utilizing versions of these molecules as possible treatments for PTB, neonatal brain injury and sepsis. Understanding the role of inflammatory processes within the major morbidities of pregnancies needs further elucidation with the hope that some benefit to mother and child may result.
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